A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

Ctr for AIDS Rostov /ID# 216289, Rostov-on-Don

Saratov Regional Center for the Prevention and Control of AIDS /ID# 216291, Saratov

Rep. Cen. of AIDS Profilactis /ID# 216292, Kazan'

Rep Center for the Prev and Control of AIDS and Inf Dis of the MoH of Chuvashia /ID# 216479, Cheboksary

Mordovian Republican Center for the Prevention and Control of AIDS /ID# 216480, Saransk

Samara region HIV/AIDS Center /ID# 216290, Samara

Reg Ctr for AIDS /ID# 216288, Chelyabinsk

GBUZ Regional Center for the P /ID# 216293, Yekaterinburg

Reg Ctr for AIDS /ID# 216295, Krasnoyarsk

GBUZ Sakhalin Regional Center for the Prevention and Control of AIDS /ID# 216478, Yuzhno-Sakhalinsk